Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Tappenden

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Journal of Comparative Effectiveness Research|December 2, 2025
Evaluating amyloid-beta as a surrogate endpoint in trials of anti-amyloid-beta drugs in Alzheimer's disease: a Bayesian meta-analysisSa Ren, Janharpreet Singh, Sandro Gsteiger, et al.
Journal of Clinical Epidemiology|November 2, 2023
Individual participant data from digital sources informed and improved precision in the evaluation of predictive biomarkers in Bayesian network meta-analysisChinyereugo M Umemneku-Chikere, Lorna Wheaton, Heather Poad, et al.
Journal of Health Services Research & Policy|April 18, 2008
Modelling the expected net benefits of interventions to reduce the burden of medication errorsJonathan Karnon, Aileen McIntosh, Joanne Dean, et al.
Health Technology Assessment (Winchester, England)|January 6, 2022
Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-frameworkPeter Murphy, David Glynn, Sofia Dias, et al.
BMC Neurology|January 8, 2009
The Multiple Sclerosis Risk Sharing Scheme Monitoring Study--early results and lessons for the futureMark Pickin, Cindy L Cooper, Timothy Chater, et al.
British Journal of Haematology|March 26, 2026
Results from the prospective phase 2 multicentre UK PBSC haplo trial using PTCy pre- or post-stem cellsHugues deLavallade, William Wilson, Rachel Protheroe, et al.
Thorax|September 24, 2021
Self-management intervention to reduce pulmonary exacerbations by supporting treatment adherence in adults with cystic fibrosis: a randomised controlled trialMartin J Wildman, Alicia O'Cathain, Chin Maguire, et al.
Health Technology Assessment (Winchester, England)|June 17, 2017
The clinical effectiveness of different surveillance strategies to prevent colorectal cancer in people with intermediate-grade colorectal adenomas: a retrospective cohort analysis, and psychological and economic evaluationsWendy Atkin, Amy Brenner, Jessica Martin, et al.
BMJ Open|May 21, 2025
Mesenchymal intravenous stromal cell infusions in children with recessive dystrophic epidermolysis bullosa: MissionEB protocol for a randomised, double-blinded, placebo-controlled, two-centre, crossover trial with an internal phase I dose de-escalation phase and open-label extensionMaria L Bageta, Pablo López-Balboa, Munyaradzi Dimairo, et al.
Eclinicalmedicine|November 3, 2025
Mesenchymal stromal cell infusions of umbilical cord-derived mesenchymal stromal cells in children with recessive dystrophic epidermolysis bullosa (MissionEB): a randomised, double-blind, placebo controlled, crossover, phase 3 trial with an internal phase 1 dose de-escalation phaseMaria L Bageta, Pablo Lopez-Balboa, Matt Bursnall, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Journal of Comparative Effectiveness Research|December 2, 2025
Evaluating amyloid-beta as a surrogate endpoint in trials of anti-amyloid-beta drugs in Alzheimer's disease: a Bayesian meta-analysisSa Ren, Janharpreet Singh, Sandro Gsteiger, et al.
Journal of Clinical Epidemiology|November 2, 2023
Individual participant data from digital sources informed and improved precision in the evaluation of predictive biomarkers in Bayesian network meta-analysisChinyereugo M Umemneku-Chikere, Lorna Wheaton, Heather Poad, et al.
Journal of Health Services Research & Policy|April 18, 2008
Modelling the expected net benefits of interventions to reduce the burden of medication errorsJonathan Karnon, Aileen McIntosh, Joanne Dean, et al.
Health Technology Assessment (Winchester, England)|January 6, 2022
Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-frameworkPeter Murphy, David Glynn, Sofia Dias, et al.
BMC Neurology|January 8, 2009
The Multiple Sclerosis Risk Sharing Scheme Monitoring Study--early results and lessons for the futureMark Pickin, Cindy L Cooper, Timothy Chater, et al.
British Journal of Haematology|March 26, 2026
Results from the prospective phase 2 multicentre UK PBSC haplo trial using PTCy pre- or post-stem cellsHugues deLavallade, William Wilson, Rachel Protheroe, et al.
Thorax|September 24, 2021
Self-management intervention to reduce pulmonary exacerbations by supporting treatment adherence in adults with cystic fibrosis: a randomised controlled trialMartin J Wildman, Alicia O'Cathain, Chin Maguire, et al.
Health Technology Assessment (Winchester, England)|June 17, 2017
The clinical effectiveness of different surveillance strategies to prevent colorectal cancer in people with intermediate-grade colorectal adenomas: a retrospective cohort analysis, and psychological and economic evaluationsWendy Atkin, Amy Brenner, Jessica Martin, et al.
BMJ Open|May 21, 2025
Mesenchymal intravenous stromal cell infusions in children with recessive dystrophic epidermolysis bullosa: MissionEB protocol for a randomised, double-blinded, placebo-controlled, two-centre, crossover trial with an internal phase I dose de-escalation phase and open-label extensionMaria L Bageta, Pablo López-Balboa, Munyaradzi Dimairo, et al.
Eclinicalmedicine|November 3, 2025
Mesenchymal stromal cell infusions of umbilical cord-derived mesenchymal stromal cells in children with recessive dystrophic epidermolysis bullosa (MissionEB): a randomised, double-blind, placebo controlled, crossover, phase 3 trial with an internal phase 1 dose de-escalation phaseMaria L Bageta, Pablo Lopez-Balboa, Matt Bursnall, et al.
Pageof 9